Freeport-McMoRan Inc. (ETR:FPMB)

Verve Therapeutics Revenue

Freeport-McMoRan had revenue of $7.58B USD in the quarter ending June 30, 2025, with 14.46% growth. This brings the company's revenue in the last twelve months to $25.82B, up 4.64% year-over-year. In the year 2024, Freeport-McMoRan had annual revenue of $25.46B with 11.38% growth.

• Revenue (ttm): $25.82B
• Revenue Growth: +4.64%
• P/S Ratio: 2.26
• Revenue / Employee: $905.96K
• Employees: 28,500
• Market Cap: 49.79B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	25.46B	2.60B	11.38%
Dec 31, 2023	22.86B	75.00M	0.33%
Dec 31, 2022	22.78B	-65.00M	-0.28%
Dec 31, 2021	22.85B	8.65B	60.90%
Dec 31, 2020	14.20B	-204.00M	-1.42%